alexa The Use of Proteomics to Dissect the Molecular Specific
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

The Use of Proteomics to Dissect the Molecular Specificities of T Cells in Type 1 Diabetes

Nadine L. Dudek*, Kailin Giam and Anthony W. Purcell

Department of Biochemistry and Molecular Biology, Monash University, Australia

Corresponding Author:
Nadine L. Dudek
Department of Biochemistry and Molecular Biology
Monash University, Clayton
Victoria 3800, Australia
Tel: +61399051557
E-mail: [email protected]

Received Date: June 11, 2013; Accepted Date: July 15, 2013; Published Date: July 21, 2013

Citation: Dudek NL, Giam K, Purcell AW (2013) The Use of Proteomics to Dissect the Molecular Specificities of T Cells in Type 1 Diabetes. J Diabetes Metab S12:006. doi:10.4172/2155-6156.S12-006

Copyright: © 2013 Dudek NL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Presentation of peptides derived from beta cell proteins to autoreactive lymphocytes is critical for the development and progression of type 1 diabetes. How tolerance to beta cell antigens is broken is yet to be fully elucidated. The high metabolic demand on beta cells, the high concentration of granule proteins and the susceptibility of islets to cellular stress may all contribute to the presentation of abnormal ligands in the pancreas. Evidence for nonconventional presentation of peptide ligands and post-translational modification of peptides to T cells has emerged in both human studies and animal models of diabetes. Challenges in identifying targets of autoimmunity are being increasingly met by advances in modern mass spectrometry. Here we review recent advances in mass spectrometry and their application to studies of peptides involved in immune recognition in diabetes.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords